as on January 21, 2026 at 8:43 pm IST
Day's Low
0.14%
Downside
52 Week's Low
52 Week's High
90.17%
Downside
-0.02%
Upside
Check Rapt Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$972.7M
EPS (TTM)
-2.5115
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-111.7M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-85.37%
Compare market cap, revenue, PE, and other key metrics of Rapt Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $972.7M | -65.3% | NA | 0.00% | |
| BUY | $47.4B | 113.21% | 1237.91 | 1.36% | |
| BUY | $113.2B | 85.25% | 31.06 | 31.35% | |
| NA | $37.4B | NA | 663.12 | 1.38% | |
| BUY | $77.7B | 37.03% | 17.57 | 32.13% |
The Rapt Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Rapt Therapeutics Inc investment value today
Current value as on today
₹6,06,241
Returns
₹5,06,241
(+506.24%)
Returns from Rapt Therapeutics Inc Stock
₹5,00,208 (+500.21%)
Dollar Returns*
₹6,033 (+6.03%)
Based on 17 analysts
64.71%
Buy
35.29%
Hold
0.00%
Sell
Based on 17 analysts, 64.71% of analysts recommend a 'BUY' rating for Rapt Therapeutics Inc. Average target price of $68.75
Get share price movements and forecasts by analysts on Rapt Therapeutics Inc.
What analysts predicted
16.19%UPSIDE
Target Price
$68.75
Current Price
$57.62
Analyzed by
17 Analysts
Target
$68.75
Rapt Therapeutics Inc target price $68.75, a slight upside of 16.19% compared to current price of $57.62. According to 17 analysts rating.
Search interest for Rapt Therapeutics Inc Stock has decreased by -41% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 20 January
Tue, 04:24 PM
-GSK agrees to acquire RAPT Therapeutics for $58 per share, valuing the company at $2.2 billion.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, RAPT stock has moved up by 65.8%
Best in 1 Year
![]()
In the last 1 year, RAPT has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.5% return, outperforming this stock by 100.0%
| Organisation | Rapt Therapeutics Inc |
| Headquarters | 561 Eccles Avenue, South San Francisco, CA, United States, 94080 |
| Industry | Health Technology |
| CEO | Dr. Brian Russell Wong M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Steve Young Ph.D. | Vice President of Technology |
Mr. Michael Listgarten | General Counsel |
Ms. Gwen R. Carscadden | Chief Human Resources Officer |
Dr. Paul Kassner Ph.D. | Senior Vice President of Biology |
Dr. Brian Russell Wong M.D., Ph.D. | CEO, President & Director |
Mr. Rodney K. B. Young | CFO, Principal Accounting Officer & Secretary |
Dr. William Ho M.D., Ph.D. | Strategic Consultant |
Dr. Dirk G. Brockstedt Ph.D. | Chief Scientific Officer |
Ms. Jennifer Nicholson | Senior Vice President of Regulatory Affairs & Quality Assurance |
Dr. Nipun Davar MBA, Ph.D. | Senior Vice President of Technical Operations |
Rapt Therapeutics Inc share price today is $57.62 as on . Rapt Therapeutics Inc share today touched a day high of $57.62 and a low of $57.54.
Rapt Therapeutics Inc share touched a 52 week high of $57.61 on and a 52 week low of $5.67 on . Rapt Therapeutics Inc stock price today i.e. is trending at $57.62,which is -0.02% down from its 52 week high and 917.09% up from its 52 week low.
Rapt Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Rapt Therapeutics Inc (RAPT) shares with as little as ₹91.673 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹916.73 in Rapt Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Rapt Therapeutics Inc share’s latest price of $57.62 as on January 21, 2026 at 8:43 pm IST, you will get 0.1736 shares of Rapt Therapeutics Inc. Learn more about
fractional shares .
Rapt Therapeutics Inc stock has given -65.3% share price returns and 24.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?